Երկիր: Սինգապուր
Լեզու: անգլերեն
Աղբյուրը: HSA (Health Sciences Authority)
AMLODIPINE BESYLATE
VIATRIS PRIVATE LIMITED
C08CA01
10 mg
TABLET
AMLODIPINE BESYLATE 10 mg
ORAL
Prescription Only
Pfizer Pharmaceuticals LLC (bulk product manufacturer)
ACTIVE
1990-12-28
_ _ 1 NORVASC Amlodipine Besylate 1. NAME OF THE MEDICINAL PRODUCT NORVASC 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: amlodipine besylate. The tablets contain amlodipine besylate equivalent to 5 mg and 10 mg amlodipine. 3. PHARMACEUTICAL FORM Tablets. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications HYPERTENSION Amlodipine is indicated for the first-line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, alpha blockers, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme (ACE) inhibitor. CORONARY ARTERY DISEASE _ _ _ _ _Chronic Stable Angina _ Amlodipine is indicated for the symptomatic treatment of chronic stable angina.Amlodipine may be used alone or in combination with other antianginal drugs. _Vasospastic_ _Angina (Prinzmetal’s or variant angina)_ Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy, or in combination with other antianginal drugs. _ _ 2 _Angiographically Documented Coronary Artery Disease _ In patients with recently documented coronary artery disease (CAD) by angiography and without heart failure or an ejection fraction <40%, amlodipine is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure. 4.2 Կարդացեք ամբողջական փաստաթուղթը
NORVASC Amlodipine Besylate 1. NAME OF THE MEDICINAL PRODUCT NORVASC 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: amlodipine besylate. The tablets contain amlodipine besylate equivalent to 5 mg and 10 mg amlodipine. 3. PHARMACEUTICAL FORM Tablets. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications HYPERTENSION Amlodipine is indicated for the first-line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, alpha blockers, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme (ACE) inhibitor. CORONARY ARTERY DISEASE _Chronic Stable Angina _ Amlodipine is indicated for the symptomatic treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal drugs. _Vasospastic_ _Angina (Prinzmetal’s or Variant Angina)_ Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy, or in combination with other antianginal drugs. _Angiographically Documented Coronary Artery Disease _ In patients with recently documented coronary artery disease (CAD) by angiography and without heart failure or an ejection fraction <40%, amlodipine is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure. 4.2 Posology and method of administration For both hypertension and angina, the usual initial dose is 5 mg amlodipine once daily, which may be increased to a maximum dose of 10 mg depending on the individual patient’s response. For patients with coronary artery disease, the recommended dosage range is 5 mg to 10 mg once daily. In clinical studies, the majority of patients required 10 mg once daily (see section 5.1. Pharmacodynamic properties - _Use in Patients with Coronary Artery Disease_ ). No dos Կարդացեք ամբողջական փաստաթուղթը